Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human Axl Fc Chimera Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
Supplier: R&D Systems™ 154AL100
This item is not returnable.
View return policy
Description
The Recombinant Human Axl Fc Chimera Protein is derived from NS0. The Recombinant Human Axl Fc Chimera Protein has been validated for the following applications: Binding Activity.Specifications
Lyophilized from a 0.2μm filtered solution in PBS. | |
71.7 kDa (monomer) | |
100μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
<0.1 EU per 1μg of the protein by the LAL method. | |
Unconjugated | |
90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
558 | |
Axl Fc Chimera | |
Mouse myeloma cell line,NS0-derived human Axl protein, (N-terminus) Human Axl (Glu33-Pro440) Accession &Num; AAA61243 DIEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus) | |
Disulfide-linked homodimer | |
AI323647, ARK, AXL oncogene, AXL receptor tyrosine kinase, AXL transforming sequence/gene, EC 2.7.10, EC 2.7.10.1, JTK11, Tyro7, tyrosine-protein kinase receptor UFO, UFO, UFOoncogene AXL | |
Recombinant |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction